Taru A. Hallinen
Kuopio, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Ustekinumab for ulcerative colitis: a nationwide real-life observational cohort study.
Journal: European journal of gastroenterology & hepatology
Published: February 19, 2025
Cost-Effectiveness of Empagliflozin in Combination with Standard Care versus Standard Care Only in the Treatment of Heart Failure Patients in Finland.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: October 10, 2022
Guselkumab Treatment Outcomes and Persistence in a Nationwide Real-world Cohort of Patients with Plaque Psoriasis.
Journal: Acta dermato-venereologica
Published: December 14, 2021
Cost-Effectiveness of Apixaban versus Other Direct Oral Anticoagulants and Warfarin in the Prevention of Thromboembolic Complications Among Finnish Patients with Non-Valvular Atrial Fibrillation.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: April 22, 2021
A nationwide real-world study on dynamic ustekinumab dosing and concomitant medication use among Crohn's disease patients in Finland.
Journal: Scandinavian journal of gastroenterology
Published: April 06, 2021
Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn's disease cohort.
Journal: European journal of gastroenterology & hepatology
Published: September 02, 2020
Relationship of faecal calprotectin and long-term outcomes in Finnish patients with Crohn's disease: retrospective multi-centre chart review study.
Journal: Scandinavian journal of gastroenterology
Published: September 19, 2019
Ustekinumab for Crohn's disease: a nationwide real-life cohort study from Finland (FINUSTE).
Journal: Scandinavian journal of gastroenterology
Published: June 12, 2019
Cost-effectiveness of pulse-echo ultrasonometry in osteoporosis management.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: June 09, 2018
Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: September 30, 2016
Cost-effectiveness of apixaban and warfarin in the prevention of thromboembolic complications among atrial fibrillation patients.
Journal: SpringerPlus
Published: November 26, 2015
Cost-utility of first-line actinic keratosis treatments in Finland.
Journal: Advances in therapy
Published: April 09, 2015
Last Updated: 09/26/2026